Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation

被引：0
|
作者：
Spica, Davide [1 ]
Junker, Till [2 ]
Dickenmann, Michael [1 ]
Schaub, Stefan [1 ]
Steiger, Jurg [1 ]
Rufli, Tanja [2 ]
Halter, Jorg [2 ]
Hopfer, Helmut [3 ]
Holbro, Andreas [2 ]
Hirt-Minkowski, Patricia [1 ]
机构：
[1] Univ Hosp Basel, Transplantat Immunol & Nephrol, Basel, Switzerland
[2] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[3] Univ Spital Basel, Inst Med Genet & Pathol, Basel, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2019年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 9
引用
收藏
页码：14S / 15S
页数：2
相关论文
共 50 条
  • [1] Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 149 - 157
  • [2] REVERSAL OF REFRACTORY ANTIBODY-MEDIATED REJECTION IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION BY ECULIZUMAB
    Morath, C.
    Kirschfink, M.
    Waldherr, R.
    Becker, L. E.
    Kihm, L. P.
    Schaier, M.
    Schwenger, V.
    Schmidt, J.
    Hohenfellner, M.
    Leo, A.
    Opelz, G.
    Suesal, C.
    Zeier, M.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 34 - 34
  • [3] ABO Antibody Titer and Risk of Antibody-Mediated Rejection in ABO-Incompatible Renal Transplantation
    Tobian, A. A. R.
    Shirey, R. S.
    Montgomery, R. A.
    Cai, W.
    Haas, M.
    Ness, P. M.
    King, K. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1247 - 1253
  • [4] The Significance of Microvascular Inflammation in Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
    Ishihara, H.
    Ishida, H.
    Unagami, K.
    Hirai, T.
    Okumi, M.
    Omoto, K.
    Shimizu, T.
    Tanabe, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 601 - 602
  • [5] IMPACT OF INFECTIOUS COMPLICATIONS ON ANTIBODY-MEDIATED REJECTION AFTER ABO-INCOMPATIBLE KIDNEY TRANSPLANTATIONS
    Kwon, Hyunwook
    Kim, Young Hoon
    Kim, Dong Hyun
    Ko, Youngmin
    Jung, Joo Hee
    Han, Duck Jong
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 395 - 395
  • [6] Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation
    Maenosono, Ryoichi
    Unagami, Kohei
    Kakuta, Yoichi
    Furusawa, Miyuki
    Okumi, Masayoshi
    Azuma, Haruhito
    Ishida, Hideki
    Tanabe, Kazunari
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (12) : 1114 - 1120
  • [7] Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
    de Weerd, Annelies
    Vonk, Alieke
    van der Hoek, Hans
    van Groningen, Marian
    Weimar, Willem
    Betjes, Michiel
    van Agteren, Madelon
    [J]. BMC NEPHROLOGY, 2014, 15
  • [8] Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
    Annelies de Weerd
    Alieke Vonk
    Hans van der Hoek
    Marian van Groningen
    Willem Weimar
    Michiel Betjes
    Madelon van Agteren
    [J]. BMC Nephrology, 15
  • [9] Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption
    Just, Soren Andreas
    Marcussen, Niels
    Sprogoe, Ulrik
    Koefoed-Nielsen, Pernille
    Bistrup, Claus
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (01) : 310 - 313
  • [10] Association between Response to Rituximab and Risk of Antibody-Mediated Rejection in ABO-Incompatible Living Kidney Transplantation
    Kakuta, Y.
    Okumi, M.
    Kanzawa, T.
    Unagami, K.
    Ishida, H.
    Tanabe, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 898 - 898
12345